Carbonic anhydrase II deficiency syndrome with amelogenesis imperfecta linked to a homozygous CA2 deletion.

IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL Intractable & rare diseases research Pub Date : 2023-08-01 DOI:10.5582/irdr.2023.01033
Luan Deives Rodrigues Leite, Kêmelly Karolliny Moreira Resende, Lídia Dos Santos Rosa, Juliana Forte Mazzeu, Livia Claudio de Oliveira, Maria do Carmo Sorci Dias Scher, Ana Carolina Acevedo, Paulo Marcio Yamaguti
{"title":"Carbonic anhydrase II deficiency syndrome with amelogenesis imperfecta linked to a homozygous <i>CA2</i> deletion.","authors":"Luan Deives Rodrigues Leite,&nbsp;Kêmelly Karolliny Moreira Resende,&nbsp;Lídia Dos Santos Rosa,&nbsp;Juliana Forte Mazzeu,&nbsp;Livia Claudio de Oliveira,&nbsp;Maria do Carmo Sorci Dias Scher,&nbsp;Ana Carolina Acevedo,&nbsp;Paulo Marcio Yamaguti","doi":"10.5582/irdr.2023.01033","DOIUrl":null,"url":null,"abstract":"<p><p>We performed a study to present a phenotypic and genotypic characterization of a patient clinically diagnosed with carbonic anhydrase II (CAII) deficiency syndrome. Medical records were reviewed, and oral examination was performed. Sanger sequencing was undertaken for molecular diagnosis. The patient presented with osteopetrosis, renal tubular acidosis, cerebral calcification, blindness, deafness, and development delay. The oral manifestations included anterior open bite, posterior crossbite, tooth eruption impairment, and hypoplastic amelogenesis imperfecta (AI). Molecular analysis revealed a <i>CA2</i> homozygous deletion (c.753delG, p.Asn252Thrfs*14) and confirmed the clinical diagnosis. This study suggests that AI can be another feature of CAII deficiency syndrome. For the first time, a <i>CA2</i> disease-causing variant is reported to be associated with syndromic AI.</p>","PeriodicalId":14420,"journal":{"name":"Intractable & rare diseases research","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468405/pdf/irdr-12-202.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intractable & rare diseases research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5582/irdr.2023.01033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

We performed a study to present a phenotypic and genotypic characterization of a patient clinically diagnosed with carbonic anhydrase II (CAII) deficiency syndrome. Medical records were reviewed, and oral examination was performed. Sanger sequencing was undertaken for molecular diagnosis. The patient presented with osteopetrosis, renal tubular acidosis, cerebral calcification, blindness, deafness, and development delay. The oral manifestations included anterior open bite, posterior crossbite, tooth eruption impairment, and hypoplastic amelogenesis imperfecta (AI). Molecular analysis revealed a CA2 homozygous deletion (c.753delG, p.Asn252Thrfs*14) and confirmed the clinical diagnosis. This study suggests that AI can be another feature of CAII deficiency syndrome. For the first time, a CA2 disease-causing variant is reported to be associated with syndromic AI.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
碳酸酐酶II缺乏症与纯合CA2缺失相关的无淀粉性发育不全。
我们进行了一项研究,以介绍临床诊断为碳酸酐酶II (CAII)缺乏综合征的患者的表型和基因型特征。审查了医疗记录,并进行了口腔检查。进行Sanger测序进行分子诊断。患者表现为骨质疏松、肾小管酸中毒、脑钙化、失明、耳聋和发育迟缓。口腔表现包括前牙合、后牙合、出牙损伤、发育不全等。分子分析显示CA2纯合缺失(c.753delG, p.Asn252Thrfs*14),证实临床诊断。这项研究表明,AI可能是CAII缺乏症的另一个特征。首次报道了一种CA2致病变异与综合征性AI相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Intractable & rare diseases research
Intractable & rare diseases research MEDICINE, GENERAL & INTERNAL-
CiteScore
2.10
自引率
0.00%
发文量
29
期刊最新文献
A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma. Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China. Epidemiological estimates of paroxysmal nocturnal hemoglobinuria in Bulgaria. Functional impairments in NBIA patients: Preliminary results. Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1